¼ºÎø¤Ê¤É¤ÎÈᤷ¤ß¤Ç¿´¤¬Äˤळ¤È¤ò½ý¿´¤È¤¤¤¤¤Þ¤¹¤¬¡¢¼ç¤ËÀº¿ÀŪ¤Ê¥¹¥È¥ì¥¹¤Çʸ»úÄ̤꿴¡¤¬¥À¥á¡¼¥¸¤ò¼õ¤±¡¢»à¤Ë»ê¤ë¥±¡¼¥¹¤â¤¢¤ë¤³¤È¤¬²Ê³ØÅª¤Ë΢ÉÕ¤±¤é¤ì¤Æ¤¤¤Þ¤¹¡£³¤³°¤Ç¯¤Ë¡Ö¥Ö¥í¡¼¥¯¥ó¥Ï¡¼¥È¾É¸õ·²(broken heart syndrome)¡×¡¢ÀìÌçÍѸì¤Ç¡Ö¤¿¤³¤Ä¤Ü¿´¶Ú¾É(takotsubo cardiomyopathy)¡×¤È¸Æ¤Ð¤ì¤ëÆÍÁ³¤Î¿´¼À´µ¤Ç»àË´¤¹¤ë¥ê¥¹¥¯¤Ï¡¢½÷À­¤ËÈæ¤Ù¤ÆÃËÀ­¤ÎÊý¤¬2Çܰʾå¹â¤¤¤³¤È¤¬¡¢¿·¤·¤¤¸¦µæ¤Ë¤è¤êȽÌÀ¤·¤Þ¤·¤¿¡£

High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years | Journal of the American Heart Association

https://www.ahajournals.org/doi/10.1161/JAHA.124.037219

Men Are Dying From 'Broken Heart Syndrome' at Twice The Rate of Women : ScienceAlert

https://www.sciencealert.com/men-are-dying-from-broken-heart-syndrome-at-twice-the-rate-of-women



¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤Ï¿´Â¡¤Îº¸¿´¼¼¤ÇȯÀ¸¤¹¤ë²ÄµÕŪ¤Êµ¡Ç½ÉÔÁ´¤Ç¡¢Í½¸å¤Ï°ìÈÌŪ¤ËÎɹ¥¤È¤µ¤ì¤Æ¤ª¤ê¡¢¼«Á³¤Ë¼£¤ë¤³¤È¤â¿¤¤¿´¼À´µ¤Ç¤¹¤¬¡¢²óÉü¸å¤Î·Ð²á¤ä¹çÊ»¾É¤Ë¤Ä¤¤¤Æ¤Ï¤Û¤È¤ó¤É¤ï¤«¤Ã¤Æ¤¤¤Þ¤»¤ó¡£

¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤È¤½¤ì¤Ë´ØÏ¢¤¹¤ë¿´·ì´É¹çÊ»¾É¤ÎȯÀ¸Î¨¤òÌÀ¤é¤«¤Ë¤¹¤ë¤¿¤á¡¢¥¢¥ê¥¾¥ÊÂç³Ø¤Î¸¦µæ¥°¥ë¡¼¥×¤Ï¡¢2016ǯ¤«¤é2020ǯ¤Ë¤«¤±¤Æ¥¢¥á¥ê¥«¤ÇÊó¹ð¤µ¤ì¤¿À®¿Í¤Î¤¿¤³¤Ä¤Ü¿´¶Ú¾É´µ¼Ô19Ëü9890¿Í¤Î¥Ç¡¼¥¿¤òʬÀϤ·¤Þ¤·¤¿¡£



ʬÀϤηë²Ì¡¢¤¿¤³¤Ä¤Ü¿´¶Ú¾É´µ¼Ô¤Î83¡ó¤¬½÷À­¤Ç¡¢Á´ÂÎŪ¤Ê»à˴Ψ¤Ï6.5¡ó¤Ç¤¢¤ê¡¢¤³¤Î»à˴Ψ¤ÏʬÀÏÂоݤȤʤä¿´ü´ÖÃæ¤Ë¤Û¤È¤ó¤É²þÁ±¤µ¤ì¤Æ¤¤¤Ê¤¤¤³¤È¤¬¤ï¤«¤ê¤Þ¤·¤¿¡£

¤Þ¤¿¹çÊ»¾É¤ÎȯÀ¸Î¨¤â¿¼¹ï¤Ç¡¢¿´¸¶À­¥·¥ç¥Ã¥¯¤Ï6.6¡ó¡¢¿´Ë¼ºÙư¤Ï20.7¡ó¡¢¿´Ää»ß¤Ï3.4¡ó¡¢¤¦¤Ã·ìÀ­¿´ÉÔÁ´¤Ï35.9¡ó¡¢Ç¾Â´Ãæ¤Ï5.3¡ó¤Ç¤·¤¿¡£

¥¢¥ê¥¾¥ÊÂç³Ø¤Î¿´Â¡ÀìÌç°å¤Ç¡¢ÏÀʸ¤ÎÉ®Æ¬Ãø¼Ô¤Î¥â¥Ï¥Þ¥É¡¦¥ì¥¶¡¦¥â¥Ð¥Ø¥É»á¤Ï¡Ö5ǯ´Ö¤Î¸¦µæ´ü´ÖÃæ¡¢¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤Ë¤è¤ë»à˴Ψ¤ÏÂ礭¤ÊÊѲ½¤¬¤Ê¤«¤Ã¤¿¤Ë¤â¤«¤«¤ï¤é¤ºÈæ³ÓŪ¹â¤¤¤Þ¤Þ¤Ç¡¢Æþ±¡¹çÊ»¾É¤ÎȯÀ¸Î¨¤Ë»ê¤Ã¤Æ¤ÏÁý²Ã¤·¤Æ¤¤¤¿¤³¤È¤Ë¶Ã¤­¤Þ¤·¤¿¡×¤ÈÏ䷤Ƥ¤¤Þ¤¹¡£

´µ¼Ô¤Î¤Û¤È¤ó¤É¤¬½÷À­¤À¤Ã¤¿°ìÊý¤Ç¡¢»àË´¥ê¥¹¥¯¤Ï½÷À­¤Î5.5¡ó¤ËÂФ·¤ÆÃËÀ­¤¬11.2¡ó¤È¡¢ÃËÀ­¤ÎÊý¤¬°µÅÝŪ¤Ë¹â¤¤¤³¤È¤âȽÌÀ¤·¤Þ¤·¤¿¡£°Ê²¼¤Ï¡¢¤½¤Î¤³¤È¤òɽ¤·¤¿¥°¥é¥Õ¤Ç¡¢¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤Ë¤è¤ë»àË´¤Î³ä¹ç¤¬ÃËÀ­(ÀÄÀþ)¤È½÷À­(ÀÖÀþ)¤Çʬ¤±¤Æ¼¨¤µ¤ì¤Æ¤¤¤Þ¤¹¡£



¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤ÇÃËÀ­¤¬»àË´¤¹¤ë¥ê¥¹¥¯¤¬¹â¤¤Íýͳ¤Ï´°Á´¤Ë¤Ï¤ï¤«¤Ã¤Æ¤¤¤Þ¤»¤ó¤¬¡¢½÷À­¤ÏÀº¿ÀŪ¥¹¥È¥ì¥¹¤¬¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤Î¸¶°ø¤Ë¤Ê¤ë¥±¡¼¥¹¤¬Â¿¤¤¤Î¤ËÂФ·¡¢ÃËÀ­¤Ï¿ÈÂÎŪ¥¹¥È¥ì¥¹¤¬¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤ò°ú¤­µ¯¤³¤¹¤³¤È¤¬Â¿¤¯¡¢¿´Ää»ß¤Ë¤Ä¤Ê¤¬¤ë´í¸±À­¤âÈæ³ÓŪ¹â¤¤¤È¤Î¤³¤È¡£¤³¤¦¤·¤¿ÃËÀ­¤Î¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤ËÆÃÍ­¤Î·¹¸þ¤¬»à˴Ψ¤Î¹â¤µ¤Ë¤Ä¤Ê¤¬¤Ã¤Æ¤¤¤ë¤ª¤½¤ì¤¬¤¢¤ë¤È¡¢¸¦µæ¥°¥ë¡¼¥×¤Ï¿ä¬¤·¤Æ¤¤¤Þ¤¹¡£

¤Þ¤¿¡¢¤¿¤³¤Ä¤Ü¿´¶Ú¾É¤ÎȯÀ¸¥á¥«¥Ë¥º¥à¤Ë¤Ï¥«¥Æ¥³¡¼¥ë¥¢¥ß¥ó¤È¤¤¤¦¥Û¥ë¥â¥ó¤¬´Ø·¸¤·¤Æ¤¤¤ë¤È¹Í¤¨¤é¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢ÃËÀ­¤Ï¤³¤Î¥Û¥ë¥â¥ó¤Î¥ì¥Ù¥ë¤¬¹â¤¤¤³¤È¤¬½ÅÍפÊÍ×°ø¤Ë¤Ê¤Ã¤Æ¤¤¤ë¤È¤â»ØÅ¦¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

¥â¥Ð¥Ø¥É»á¤Ï¡Ö»à˴Ψ¤¬°ÍÁ³¤È¤·¤Æ¹â¤¤¤Î¤Ïͫθ¤¹¤Ù¤­»öÂ֤Ǥ¢¤ê¡¢¤è¤êÍ¥¤ì¤¿¼£ÎÅË¡¤ä¡¢¤³¤Îɵ¤¤ËÂФ¹¤ë¿·¤¿¤Ê¼£ÎÅË¡¤ò¸«¤Ä¤±¤ë¤¿¤á¤Ë¡¢¤µ¤é¤Ê¤ë¸¦µæ¤¬É¬ÍפǤ¹¡×¤È½Ò¤Ù¤Þ¤·¤¿¡£